Daebongls.Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
March 20, 2024 at 04:48 am EDT
Share
Daebongls.Co.,Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was KRW 0.00001 million compared to KRW 0.00001 million a year ago. Net income was KRW 4,182.17 million compared to KRW 8,627.67 million a year ago.
Basic earnings per share from continuing operations was KRW 382 compared to KRW 788 a year ago. Diluted earnings per share from continuing operations was KRW 382 compared to KRW 788 a year ago. Basic earnings per share was KRW 382 compared to KRW 788 a year ago.
Daebongls. Co., Ltd. is a Korea-based company engaged in the manufacture of raw materials for pharmaceuticals and cosmetics. The Company operates its business through two main divisions: cosmetic division, which provides aloe vera gels, beta carotens, calamines, diaformers, emulgades and others for conditioners, emulsifiers, emollients, polymers, thickeners and others; pharmaceutical division, which provides almagates, bentonites, calcitriols, erdosteines, fish oil and others for antibiotics, cough products, expectorants and others. In addition, it is involved in the provision of food chemical additives, fish feedstuff and others. The Company distributes its products within domestic market and to overseas markets, including Japan, America and other Southeast Asian countries.
DAEBONGLS.CO.,LTD. 
